SG Americas Securities’s Bristol-Myers Squibb BMY Stock Holding History

SG Americas Securities’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-15,000	Closed	-$12K	–	3250
2025 Q4	$12K	Buy	+15,000	New	+$722K	﹤0.01%	3502
2024 Q4	–	Sell	-75,300	Closed	-$45K	–	3167
2024 Q3	$45K	Buy	+75,300	New	+$3.53M	﹤0.01%	3264
2023 Q2	–	Sell	-11,500	Closed	-$53K	–	2355
2023 Q1	$53K	Sell	11,500 -84,400	-88%	-$5.95M	﹤0.01%	3062
2022 Q4	$109K	Sell	95,900 -4,000	-4%	-$302K	﹤0.01%	2658
2022 Q3	$237K	Sell	99,900 -8,600	-8%	-$624K	﹤0.01%	2173
2022 Q2	$190K	Buy	108,500 +19,700	+22%	+$1.5M	﹤0.01%	2702
2022 Q1	$201K	Sell	88,800 -17,900	-17%	-$1.2M	﹤0.01%	2429
2021 Q4	$33K	Sell	106,700 -650,000	-86%	-$38.1M	﹤0.01%	3227
2021 Q3	$5.38M	Buy	756,700 +650,000	+609%	+$42.8M	0.03%	502
2021 Q2	$45K	Sell	106,700 -200,000	-65%	-$13M	﹤0.01%	2746
2021 Q1	$1.45M	Sell	306,700 -1,653,800	-84%	-$103M	0.01%	1274
2020 Q4	$559K	Sell	1,960,500 -446,700	-19%	-$27.5M	﹤0.01%	1897
2020 Q3	$5.39M	Buy	2,407,200 +435,000	+22%	+$26.2M	0.03%	322
2020 Q2	$5.26M	Buy	1,972,200 +90,000	+5%	+$5.38M	0.04%	333
2020 Q1	$7.56M	Sell	1,882,200 -1,278,500	-40%	-$78.1M	0.07%	256
2019 Q4	$1.93M	Buy	3,160,700 +1,414,400	+81%	+$81M	0.02%	842
2019 Q3	$2.15M	Buy	1,746,300 +577,900	+49%	+$27.2M	0.02%	906
2019 Q2	$4.19M	Buy	1,168,400 +875,600	+299%	+$40.8M	0.03%	624
2019 Q1	$1.67M	Sell	292,800 -1,095,900	-79%	-$54.6M	0.02%	958
2018 Q4	$3.37M	Buy	1,388,700 +645,000	+87%	+$34.7M	0.03%	545
2018 Q3	$913K	Buy	743,700 +217,400	+41%	+$12.9M	0.01%	1760
2018 Q2	$977K	Buy	526,300 +7,500	+1%	+$405K	0.01%	1458
2018 Q1	$790K	Buy	518,800 +53,800	+12%	+$3.46M	0.01%	1539
2017 Q4	$573K	Buy	465,000 +33,400	+8%	+$2.09M	0.01%	1762
2017 Q3	$695K	Buy	431,600 +360,100	+504%	+$21M	0.01%	1551
2017 Q2	$89K	Sell	71,500 -1,896,500	-96%	-$103M	﹤0.01%	2947
2017 Q1	$17.8M	Buy	1,968,000 +1,727,000	+717%	+$94.7M	0.16%	120
2016 Q4	$105K	Sell	241,000 -12,100	-5%	-$662K	﹤0.01%	2836
2016 Q3	$1.1M	Buy	253,100 +131,100	+107%	+$8.42M	0.01%	1104
2016 Q2	$76K	Hold	122,000	–	–	﹤0.01%	2425
2016 Q1	$205K	Sell	122,000 -491,000	-80%	-$31M	﹤0.01%	2183
2015 Q4	$26K	Buy	+613,000	New	+$40.5M	﹤0.01%	2534
2015 Q3	–	Sell	-513,000	Closed	-$304K	–	2126
2015 Q2	$304K	Buy	513,000 +122,300	+31%	+$8.06M	﹤0.01%	1760
2015 Q1	$245K	Sell	390,700 -52,500	-12%	-$3.29M	﹤0.01%	1786
2014 Q4	$319K	Buy	443,200 +16,000	+4%	+$902K	﹤0.01%	2009
2014 Q3	$937K	Buy	427,200 +72,300	+20%	+$3.61M	0.01%	1181
2014 Q2	$1.04M	Buy	354,900 +254,900	+255%	+$12.6M	0.01%	1336
2014 Q1	$564K	Sell	100,000 -856,800	-90%	-$45.6M	﹤0.01%	1413
2013 Q4	$20K	Sell	956,800 -154,400	-14%	-$7.87M	﹤0.01%	2516
2013 Q3	$49K	Sell	1,111,200 -89,700	-7%	-$3.94M	﹤0.01%	2797
2013 Q2	$679K	Buy	+1,200,900	New	+$52.1M	﹤0.01%	1119

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SG Americas Securities's BMY Position: Q1 2026 in Review

SG Americas Securities increased its Bristol-Myers Squibb (BMY) stake by 240% in Q1 2026, buying an estimated $366M and bringing the position to 8,910,032 shares worth $540M. The position accounts for 0.58% of the portfolio, ranked #23.

SG Americas Securities first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

SG Americas Securities held 8,910,032 shares of Bristol-Myers Squibb worth $540M as of Q1 2026.
SG Americas Securities bought 6,286,007 Bristol-Myers Squibb shares in Q1 2026, an estimated $366M.
Bristol-Myers Squibb made up 0.58% of SG Americas Securities's portfolio in Q1 2026, its #23 holding.
SG Americas Securities first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.